Capsaicin
Check on isomerdesign
Capsaicin
Check on pubchem
Capsaicin
Check on drugmap
Capsaicin
Check on drugmap
Data
InChI: InChI=1S/C18H27NO3/c1-14(2)8-6-4-5-7-9-18(21)19-13-15-10-11-16(20)17(12-15)22-3/h6,8,10-12,14,20H,4-5,7,9,13H2,1-3H3,(H,19,21)
Synonyms: NCGC00090853-08,NCGC00090853-02,CAPSAICIN [INCI],SBI-0052593.P002,NSC-757844,ZOSTRIX (TN),7553-53-9,(6E)-N-{[4-hydroxy-3-(methyloxy)phenyl]methyl}-8-methylnon-6-enamide,TNP00277,HMS2092D21,Tox21_200315,CAPSAICIN, NATURAL,Methyl-N-vanillyl-6-noneneamide,6-Nonenamide, 8-methyl-N-vanillyl-, (E)-,(e)-n-(4-hydroxy-3-methoxybenzyl)-8-methylnon-6-enamide,NCGC00017337-07,SCHEMBL8086,4DY,SCHEMBL8085,NCGC00090853-01,E-CAPSAICIN,NCGC00090853-03,SR-05000001861-5,Capsaicin, Pharmaceutical Secondary Standard; Certified Reference Material,DB06774,MFCD00017259,AB00053098-11,NCGC00017337-04,Capsaicin (transdermal patch formulation, neuropathic pain),Capsaicin [in oleoresin of capsicum],HMS501B16,N-[(4-Hydroxy-3-methoxyphenyl)methyl]-8-methyl-6-nonenamide,CAPSAICIN (CONSTITUENT OF CAPSICUM) [DSC],Zostrix HP,neurotoxic,S07O44R1ZM,NSC_2548,CAPSAICIN [USP MONOGRAPH],HMS2089N11,BBL027836,EI-125,HMS1989N10,Pharmakon1600-01501128,Cntx-4975,depletes Substance P,Qutenza,trans-8-Methyl-N-vanillyl-6-nonenamide,Capzasin-hp,CHEMBL294199,DSSTox_RID_75455,isoamyl4-methoxycinnamate,SMP2_000337,CNTX-4975,CAS_404-86-4,Caswell No. 158,UPCMLD-DP092,Isodecenoic acid vanillylamide,(6E)-N-(4-hydroxy-3-methoxybenzyl)-8-methylnon-6-enamide,DSSTox_GSID_20241,epsilon-capsaicin,Qutenza;Vanilloid,UPCMLD-DP092:002,Mioton,NSC-56353,CHEBI:94524,CAPSAICIN [VANDF],MLS002154049,CAPSAICINE,HMS1361N10,NCGC00017337-08,N-(4-HYDROXY-3-METHOXYBENZYL)-8-METHYL-6-NONENAMIDE [FHFI],Adlea,8-Methyl-N-vanillyl-6-nonenamide,NSC757844,trans-Capsaicin-d3,NCGC00017337-03,6-Nonenamide, N-[(4-hydroxy-3-methoxyphenyl)methyl]-8-methyl-, (6E)-,8-Methyl-N-Vanillyl-6-Nonenamide,NCGC00017337-17,Capsaicin, United States Pharmacopeia (USP) Reference Standard,Capsaicin, European Pharmacopoeia (EP) Reference Standard,(E)-8-Methyl-N-vanillyl-6-nonenamide,HMS3678F11,DSSTox_CID_241,Capsaicin (8-Methyl-N-vanillyl-6-nonenamide),CAPSAICIN [USP-RS],6-nonenamide,n-((4-hydroxy-3-methoxyphenyl)methyl)-8-methyl-,(6e)-,Capsaicin (Natural),NCGC00090853-11,N-(3-Methoxy-4-hydroxybenzyl)-8-methyl-6-nonenamide,Isodecenoate,Zostrix,Capsaicinoid,Ovocap,SR-05000001861-1,(E)-Capsaicin,CHEBI:3374,CAPSAICIN [WHO-DD],HY-10448A,MR3H3,BSPBio_000957,NCGC00017337-12,Q273169,NGX-3781,Axsain,starbld0019180,EN300-7544118,NCGC00017337-10,NCGC00017337-06,Capsicine,HMS1791N10,CAPSAICINOIDS,ALGRX-4975,HMS1570P19,CCRIS 1588,NCGC00017337-09,NSC 56353,TQ-1018,Capsaicin,(S),BRD-K37056290-001-01-1,HMS3649N15,SDCCGMLS-0066678.P001,NGX-7325,CAPSAICIN [JAN],Capsaicin [USAN],FEMA No. 3404,(E)-N-[(4-hydroxy-3-methoxy-phenyl)methyl]-8-methyl-non-6-enamide,Bitter orange extract 30%,N-((4-Hydroxy-3-methoxyphenyl)methyl)-8-methyl-6-nonenamide,CAPSAICIN [EMA EPAR],8-Methyl-N-vanillyl-6-nonenamide, (E)-,C06866,IDI1_000354,6-Nonenamide, N-[(4-hydroxy-3-methoxyphenyl)methyl]-8-methyl-, (E)-,Prestwick_204,Citrus Aurantium 30%,CAPSAICIN [ORANGE BOOK],D00250,HMS3414F11,KS-5181,CAPSAICIN [HSDB],Citrus Aurantium Extract,BPBio1_001053,AB00053098_12,trans-N-((4-Hydroxy-3-methoxyphenyl)methyl)-8-methyl-6-nonenamide,CAPSAICIN [INN],Capsaicin, >=95%, from Capsicum sp.,CCG-39908,ZINC1530575,HY-10448,(6E)-N-(4-Hydroxy-3-methoxybenzyl)-8-methyl-6-nonenamide #,(E)-N-[(4-Hydroxy-3-methoxyphenyl)-methyl]-8-methyl-6-nonenamide,6-Nonenamide, (E)-,HMS2230O23,LS-14673,CAPSAICIN [MART.],BSPBio_001548,EPA Pesticide Chemical Code 070701,UPCMLD-DP092:001,Capsaicin; 8-Methyl-N-vanillyl-trans-6-nonenamide; NGX-4010,IDI1_034018,CS-0181240,Prestwick2_000879,Capsaicin [USP:INN],Capsaicin, analytical standard,BDBM20461,(6E)-N-[(4-hydroxy-3-methoxyphenyl)methyl]-8-methylnon-6-enamide,8-Methyl-N-vanillyl-6E-nonenamide,C-1700,Ratden pe 40,NCI-C56564,Capsaicin (in oleoresin of capsicum),GTPL2486,HMS1921H11,NCGC00017337-11,NCGC00017337-18,BRN 2816484,Prestwick3_000879,8-Methyl-N-vanillyl-(trans)-6-nonenamide,trans-Capsaicin,Capsaicin, certified reference material, TraceCERT(R),N1667,Capsaicin (JAN/USP),NCGC00017337-05,6-Nonenamide, N-((4-hydroxy-3-methoxyphenyl)methyl)-8-methyl-, (6E)-,Capsaicin 10 microg/mL in Acetonitrile,Ausanil,NCGC00090853-04,NGX-4010,N-(4-hydroxy-3-methoxybenzyl)-8-methylnon-6-enamide,Capsaicin,AKOS007930159,CAS-404-86-4,Togarashi orenji,N0C781,N-(4-Hydroxy-3-methoxybenzyl)-8-methylnon-trans-6-enamide,NCGC00090853-10,BRD-K50590187-001-06-6,HSDB 954,404-86-4,Dolenon,NCGC00017337-13,NGX 4010,(E)-8-Methyl-N-vanillyl-6-nonenamide(8cl),LMFA08020085,Capsaicin, from Capsicum sp., >=50% (HPLC),NCGC00090853-07,SPECTRUM1501128,UNII-S07O44R1ZM,SR-05000001861-4,N-[(4-hydroxy-3-methoxyphenyl)methyl]-6E-8-methyl-nonenamide,NCGC00090853-12,NCGC00257869-01,SR-05000001861,SMR000718774,BDBM86537,Transacin,NSC56353,(E)8-methyl-N-vanillyl-6-Nonenamide,SR-05000001861-6,CAPSAICIN [MI],HMS3402N10,CS-1518,6-Nonenamide, N-((4-hydroxy-3-methoxyphenyl)methyl)-8-methyl-, (E)-,EINECS 206-969-8,NGX-1998,1217899-52-9,DTXSID9020241,M1149,NCGC00017337-02,AMY25669,capsacin(E),6-Nonenamide, (E)-N-((4-hydroxy-3-methoxy-phenyl)methyl)-8-methyl,(E)-N-[(4-hydroxy-3-methoxyphenyl)methyl]-8-methylnon-6-enamide,Styptysat,N-((4-Hydroxy-3-methoxyphenyl)methyl)-8-methyl-6-nonenamide, (E)-,8-Methyl-N-vanillyl-trans-6-nonenamide,SR-05000001861-9,Tox21_110817,CCG-39657,BSPBio_002917,AC-10114,NCGC00090853-06,s1990,ALGRX 4975,NCGC00090853-09,(E)-N-((4-Hydroxy-3-methoxyphenyl)-methyl)-8-methyl-6-nonenamide,(E)-N-[(4-HYDROXY-3-METHOXYPHENYL)METHYL]-8-METHYL-6-NONENAMIDE,HMS2097P19,Spectrum5_000538,CITRUS AURANTIUM PE,MEGxp0_001448,Vanilloid,STL372889
Estimated data
Solubility: -4.182 (log(S) in mol/L prediction using SolTranNet)
Blood Brain Barrier Permeability: Yes (prediction using frontiersin.org)
Addictivity Prediction: 54.0% (prediction based on www.mdpi.com)
